SUGIMOTO, TAKAHIRO,杉本贵裕,杉本貴裕,SUZUKI, SHINKICHI,铃木新吉,鈴木新吉,SAKAMOTO, HIROKI,坂本辉,坂本輝,YAMADA, MASAMI,山田昌美,NAKAMURA, MINORU,中村実,KAMATA, MAKOTO,鎌田信,SHIMOKAWA, KENICHIRO,下川贤一郎,下川賢一郎,OGINO, MAS
申请号：
TW105119717
公开号：
TW201710255A
申请日:
2016.06.23
申请国别(地区):
TW
年份:
2017
代理人:
摘要：
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer’s disease, schizophrenia, pain, sleep disorder, Parkinson’s disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof: wherein each symbol is as defined in the attached description.本發明提供具有膽鹼性蕈毒M1受體正向異位性調變劑活性的化合物，其可適用作為阿滋海默症、精神分裂症、疼痛、睡眠障礙、帕金森氏症失智症、路易體失智症等之預防或治療藥物。本發明係關於式(I)表示之化合物或其鹽：其中各符號如所附說明中定義。
